BNP Paribas Financial Markets’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-11,367
| Closed | -$855K | – | 4283 |
|
2022
Q2 | $855K | Sell |
11,367
-11,662
| -51% | -$878K | ﹤0.01% | 1740 |
|
2022
Q1 | $618K | Sell |
23,029
-8,149
| -26% | -$219K | ﹤0.01% | 2102 |
|
2021
Q4 | $1.49M | Buy |
31,178
+19,917
| +177% | +$950K | ﹤0.01% | 1758 |
|
2021
Q3 | $748K | Buy |
11,261
+6,894
| +158% | +$458K | ﹤0.01% | 2001 |
|
2021
Q2 | $341K | Sell |
4,367
-628
| -13% | -$49K | ﹤0.01% | 2135 |
|
2021
Q1 | $472K | Sell |
4,995
-21,833
| -81% | -$2.07M | ﹤0.01% | 2066 |
|
2020
Q4 | $3.27M | Buy |
26,828
+18,756
| +232% | +$2.29M | 0.01% | 936 |
|
2020
Q3 | $705K | Buy |
8,072
+4,806
| +147% | +$420K | ﹤0.01% | 1458 |
|
2020
Q2 | $211K | Sell |
3,266
-10,740
| -77% | -$694K | ﹤0.01% | 1861 |
|
2020
Q1 | $626K | Buy |
14,006
+10,235
| +271% | +$457K | ﹤0.01% | 1699 |
|
2019
Q4 | $235K | Buy |
3,771
+2,822
| +297% | +$176K | ﹤0.01% | 2245 |
|
2019
Q3 | $35.7K | Buy |
949
+807
| +568% | +$30.3K | ﹤0.01% | 3028 |
|
2019
Q2 | $5.78K | Buy |
+142
| New | +$5.78K | ﹤0.01% | 3594 |
|